Keloids Treatment Market Trends and Insights: Global Forecast to 2030

Uncover key drivers, emerging technologies, and competitive movements shaping the keloids treatment market from 2026–2035 with trusted insights from The Business Research Company

What long-term size projections exist for the Keloids Treatment Market covering 2026–2035?

The keloids treatment market has experienced consistent expansion in recent years. This market is projected to expand from $4.32 billion in 2025 to $4.48 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 3.7%. Historically, this growth can be ascribed to factors such as a higher frequency of skin injuries and surgical procedures, an expanding number of individuals susceptible to keloids, the well-established application of steroid injections, a surge in demand for cosmetic dermatology solutions, and the presence of diverse treatment options.

The keloids treatment market is projected to experience consistent expansion over the upcoming years, with its size forecast to reach $5.37 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 4.6%. This anticipated growth during the forecast period is driven by progress in laser and cryotherapy techniques, increased recognition of scar management options, a growing inclination towards minimally invasive procedures, the proliferation of dermatology clinics in developing regions, and the greater uptake of at-home scar care products. Significant trends expected during this period encompass an escalating demand for non-invasive methods to treat keloids, the rising acceptance of combination therapy strategies, greater utilization of laser-based scar management, the broadening availability of homecare and topical treatment alternatives, and an emphasis on personalized and recurrence-avoiding treatments.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=12908&type=smp

Which Drivers Are Impacting The Competitive Landscape Of The Keloids Treatment Market?

The increasing occurrence of wounds and injuries is projected to fuel the expansion of the keloid treatment market. Wounds, defined as physical damage or trauma to body tissues, often involving a skin breach due to accidents, surgeries, burns, or other incidents, frequently lead to keloid development. This escalation in wound-related keloid formation boosts the need for effective treatment solutions, enhances public understanding of keloid complications, stimulates research innovation, and fosters collaboration among medical practitioners. For example, the U.S. Bureau of Labor Statistics (BLS), a US-based federal government agency, indicated in November 2024 that private sector employers recorded approximately 2.6 million nonfatal workplace injuries and illnesses during 2023. Consequently, the growing number of wound and injury cases will propel the keloid treatment market.

Keloids Treatment Market Driver: Growth Of Keloid Treatment Market Fueled By Increasing Demand For Non-Surgical Aesthetic Procedures

The rising enthusiasm for non-surgical aesthetic procedures is anticipated to advance the keloid treatment market. Non-surgical aesthetics encompass cosmetic interventions that improve appearance without requiring surgery, targeting particular issues for a more rejuvenated look. Medical professionals employ non-surgical methods like laser therapy, cryotherapy, and dermal fillers to diminish the visibility and discomfort associated with keloid scars by reducing inflammation, redness, and vascularization. As an illustration, the International Society of Aesthetic Plastic Surgery (ISAPS), a US-based nonprofit organization, reported in June 2024 that the cumulative number of surgical and non-surgical aesthetic procedures grew by 3.4% in 2023, reaching approximately 34.9 million, with about 19.1 million of these being non-surgical treatments. Thus, the escalating demand for non-surgical aesthetic procedures will stimulate the keloid treatment market.

What Segments Are Identified Within The Structure Of The Keloids Treatment Market?

The keloids treatment market covered in this report is segmented –

1) By Product Type: Topical Products, Injectable Products, Medical Devices

2) By Treatment: Radiation Therapy, Cryo Therapy, Surgical Treatment, Laser Treatment, Steroid Injections, Other Treatments

3) By Route Of Administration: Topical Administration, Intralesional Administration

4) By End User: Hospitals, Homecare, Dermatology Clinics, Other End Users

Subsegments:

1) By Topical Products: Silicone-Based Products, Steroid-Based Topical Products

2) By Injectable Products: Corticosteroid Injections, Antimetabolite Injections

3) By Medical Devices: Compression Therapy Devices, Silicone-Based Scar Management Devices

How Are Emerging Trends Affecting The Progression Of The Keloids Treatment Market?

Major companies operating in the keloid treatment market are concentrating on developing advanced scar management technologies, such as scar-erase silicone strips, to secure a competitive advantage in the market. For instance, Scar Erase, a UK-based scar treatment company, introduced Scar Erase silicone strips in April 2023 as a solution for addressing scars. These strips are crafted from 3 mm of medical-grade silicone and have been clinically proven to enhance scar appearance and facilitate healing. This reusable, vegan, and cruelty-free technology is designed to provide an affordable and convenient at-home scar treatment option suitable for various scar types, including hypertrophic, keloid, post-surgery, and stretch marks. The process involves encapsulating the scar with silicone to hydrate it and create an optimal healing environment. This action reduces collagen formation and improves scar texture, color, and height, offering both effectiveness and comfort.

Which Major Firms Are Strengthening Their Position In The Keloids Treatment Market?

Major companies operating in the keloids treatment market are Galderma S.A., Sun Pharmaceutical Industries Ltd., Stratpharma AG, Revance Therapeutics Inc., Sensus Healthcare Inc., Cynosure Inc., Cutera Inc., Lumenis Ltd., Candela Medical, Merz Pharma GmbH & Co. KGaA, AbbVie Inc., Teva Pharmaceutical Industries Ltd., Alliance Pharma plc, Sonoma Pharmaceuticals Inc., Strata Skin Sciences Inc., Avita Medical Limited, Biofrontera AG, Sinclair Pharma plc, Fotona d.o.o., Lutronic Corporation

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/keloids-treatment-global-market-report

Which Global Regions Are Shaping The Competitive Landscape Of The Keloids Treatment Market?

North America was the largest region in the keloids treatment market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the keloids treatment market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Keloids Treatment Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=12908&type=smp

Browse Through More Reports Similar to the Global Keloids Treatment Market 2026, By The Business Research Company

Kernicterus Treatment Market Report 2026

https://www.thebusinessresearchcompany.com/report/kernicterus-treatment-global-market-report

Hypertrophic And Keloid Scar Treatment Market Report 2026

https://www.thebusinessresearchcompany.com/report/hypertrophic-and-keloid-scar-treatment-global-market-report

Actinic Keratosis Treatment Market Report 2026

https://www.thebusinessresearchcompany.com/report/actinic-keratosis-treatment-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795